Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Learn how GA4GH helps expand responsible genomic data use to benefit human health.
Our Strategic Road Map defines strategies, standards, and policy frameworks to support responsible global use of genomic and related health data.
Discover how a meeting of 50 leaders in genomics and medicine led to an alliance uniting more than 5,000 individuals and organisations to benefit human health.
GA4GH Inc. is a not-for-profit organisation that supports the global GA4GH community.
To guide our collaborative, globe-spanning alliance, GA4GH relies on a Standards Steering Committee and an Executive Committee.
The Funders Forum brings together organisations that offer both financial support and strategic guidance.
The EDI Advisory Group responds to issues raised in the GA4GH community, finding equitable, inclusive ways to build products that benefit diverse groups.
Distributed across four Host Institutions, our staff team supports the mission and operations of GA4GH.
Curious who we are? Meet the people and organisations across six continents who make up GA4GH.
More than 500 organisations connected to genomics — in healthcare, research, patient advocacy, industry, and beyond — have signed onto the mission and vision of GA4GH as Organisational Members.
These core Organisational Members are genomic data initiatives that have committed resources to guide GA4GH work and pilot our products.
This subset of Organisational Members whose networks or infrastructure align with GA4GH priorities has made a long-term commitment to engaging with our community.
Local and national organisations assign experts to spend at least 30% of their time building GA4GH products.
Anyone working in genomics and related fields is invited to participate in our inclusive community by creating and using new products.
Wondering what GA4GH does? Learn how we find and overcome challenges to expanding responsible genomic data use for the benefit of human health.
Study Groups define needs. Participants survey the landscape of the genomics and health community and determine whether GA4GH can help.
Work Streams create products. Community members join together to develop technical standards, policy frameworks, and policy tools that overcome hurdles to international genomic data use.
GIF solves problems. Organisations in the forum pilot GA4GH products in real-world situations. Along the way, they troubleshoot products, suggest updates, and flag additional needs.
NIF finds challenges and opportunities in genomics at a global scale. National programmes meet to share best practices, avoid incompatabilities, and help translate genomics into benefits for human health.
Communities of Interest find challenges and opportunities in areas such as rare disease, cancer, and infectious disease. Participants pinpoint real-world problems that would benefit from broad data use.
See all our products — always free and open-source. Do you work on cloud genomics, data discovery, user access, data security or regulatory policy and ethics? Need to represent genomic, phenotypic, or clinical data? We’ve got a solution for you.
All GA4GH standards, frameworks, and tools follow the Product Development and Approval Process before being officially adopted.
Learn how other organisations have implemented GA4GH products to solve real-world problems.
Help us transform the future of genomic data use! See how GA4GH can benefit you — whether you’re using our products, writing our standards, subscribing to a newsletter, or more.
Help create new global standards and frameworks for responsible genomic data use.
Align your organisation with the GA4GH mission and vision.
Solve your real-world data problems with support from this valuable network of global institutions.
Work with like-minded groups committed to better data use in areas like rare disease, cancer, and infectious disease.
Share your thoughts on all GA4GH products currently open for public comment.
Solve real problems by aligning your organisation with the world’s genomics standards. We offer software dvelopers both customisable and out-of-the-box solutions to help you get started.
Learn more about upcoming GA4GH events. See reports and recordings from our past events.
Speak directly to the global genomics and health community while supporting GA4GH strategy.
Be the first to hear about the latest GA4GH products, upcoming meetings, new initiatives, and more.
Questions? We would love to hear from you.
Read news, stories, and insights from the forefront of genomic and clinical data use.
Attend an upcoming GA4GH event, or view meeting reports from past events.
See new projects, updates, and calls for support from the Work Streams.
Read academic papers coauthored by GA4GH contributors.
Listen to our podcast OmicsXchange, featuring discussions from leaders in the world of genomics, health, and data sharing.
Check out our videos, then subscribe to our YouTube channel for more content.
View the latest GA4GH updates, Genomics and Health News, Implementation Notes, GDPR Briefs, and more.
Discover all things GA4GH: explore our news, events, videos, podcasts, announcements, publications, and newsletters.
1 Nov 2019
The European Joint Programme on Rare Diseases (EJP RD) is a GA4GH Driver Project working towards the advancement and innovation of rare disease research, funding, diagnosis, treatments, and clinical trials. The Driver Project recently shared the story of a patient named Yakup, whose family had spent years searching for answers to a set of neurological symptoms that afflicted him since birth.
The European Joint Programme on Rare Diseases (EJP RD) is a GA4GH Driver Project working towards the advancement and innovation of rare disease research, funding, diagnosis, treatments, and clinical trials. The Driver Project recently shared the story of a patient named Yakup, whose family had spent years searching for answers to a set of neurological symptoms that afflicted him since birth. Yakup’s family had already experienced a loss because of this mysterious disease: his oldest brother passed away with similar symptoms several years ago.
Yakup and his family underwent genetic testing through a research study called CONSEQUITUR, to identify the cause of his disease. Their genetic samples were then analyzed and shared with the RD–Connect Genome Phenome Analysis Platform (GPAP)—a resource originally developed within the EU project RD-Connect and now included as part of the EJP RD. The GPAP allows researchers and clinicians around the world to collaborate in the genetic diagnosis of rare disease patients by providing a user-friendly interface for analyzing phenotypic and genomic data together. The platform facilitates a multidisciplinary approach, in that several researchers and clinicians from different fields, institutions, and countries can collaborate on one patient’s case to identify the underlying cause of disease.
“The RD-Connect platform is an online system that enables researchers and clinicians to diagnose rare disease patients,” said Sergi Beltran, who leads the Bioinformatics Unit at the National Center of Genomic Analysis (CNAG-CRG) and is a Champion representing the EJP RD as a GA4GH Driver Project. He also indicated that “it is essential to share data to improve and accelerate diagnosis; if a clinician or researcher has sequenced a patient’s genome or exome and cannot reach a diagnosis, others might be able to do it or will have similar cases to support new findings.”
In the context of rare disease, data sharing and genetic testing can give families a final molecular diagnosis, as it did for Yakup and his family. This helps doctors to tailor treatment to their specific disease and allows families to better plan for the future.
“Data portray knowledge, and so it is imperative that we find ever-better ways to share and utilise the wealth of research and healthcare data being routinely generated to help understand and treat disease,” said Anthony Brookes, who is also a Driver Project Champion representing the EJP RD and who leads Health Data Science activities as a Professor of Genome and Bioinformatics at the University of Leicester. “Tackling Rare Disease this way is becoming increasingly possible, but improvements in handling ethical and legal issues, as well as better technical and data standardisation, are still needed if we are to complete this mission.”
The EJP RD joined GA4GH as a Driver Project in 2019 because of the efforts put forth by GA4GH to standardize genomic and health data sharing across institutions, countries, and professions. The EJP RD collaborates via active contribution in many of the GA4GH Work Streams, such as the Regulatory and Ethics Work Stream and Clinical and Phenotypic Data Capture Work Stream, to develop standards that meet rare disease data sharing needs.
“We think that the collaboration between the EJP RD and GA4GH is already very successful,” said Beltran. “In the GPAP and other resources included in the EJP RD we are using and adopting many of the GA4GH standards such as Beacon, Phenopackets, htsget, Read File Formats, and Genetic Variant Formats. We are also expanding the involvement of the EJP RD to engage with all of the GA4GH Work Streams in the development of future standards.”